Technical Analysis for RTTR - Ritter Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade F 0.82 0.35% 0.00
RTTR closed up 0.35 percent on Friday, May 24, 2019, on 22 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical RTTR trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
Oversold Stochastic Weakness 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.35%
Stochastic Buy Signal Bullish 0.35%
Narrow Range Bar Range Contraction 0.35%
NR7 Range Contraction 0.35%
Oversold Stochastic Weakness 0.35%
Earnings Movers Other -1.20%

Older signals for RTTR ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Ritter Pharmaceuticals, Inc. develops novel therapeutic products, which modulate the human gut microbiome to treat inflammatory, gastrointestinal, and metabolic diseases. Its lead product candidate is RP-G28, a novel microbiome modulator, which is under development for the reduction of symptoms associated with lactose intolerance. RP-G28 is designed to stimulate the growth of lactose-metabolizing bacteria in the colon, thereby adapting the gut microbiome to assist in digesting the lactose that reaches the large intestine. RP-G28 has been studied in a Phase 2a clinical trial. The company was formerly known as Ritter Natural Sciences, LLC and changed its name to Ritter Pharmaceuticals, Inc. in September 2008. Ritter Pharmaceuticals, Inc. was founded in 2004 and is headquartered in Los Angeles, California.
Medicine Medical Specialties Therapeutic Products Metabolic Diseases Bacteriology Digestive System Inflammatory Large Intestine Milk Therapeutic
Is RTTR a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 4.0
52 Week Low 0.47
Average Volume 433,290
200-Day Moving Average 1.1188
50-Day Moving Average 0.9031
20-Day Moving Average 0.8496
10-Day Moving Average 0.8396
Average True Range 0.0723
ADX 18.38
+DI 22.5637
-DI 16.2878
Chandelier Exit (Long, 3 ATRs ) 0.9531
Chandelier Exit (Short, 3 ATRs ) 0.9669
Upper Bollinger Band 0.9718
Lower Bollinger Band 0.7274
Percent B (%b) 0.38
BandWidth 28.766478
MACD Line -0.017
MACD Signal Line -0.0116
MACD Histogram -0.0054
Fundamentals Value
Market Cap 12.11 Million
Num Shares 14.8 Million
EPS -1.33
Price-to-Earnings (P/E) Ratio -0.62
Price-to-Sales 0.00
Price-to-Book 1.81
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.87
Resistance 3 (R3) 0.87 0.86 0.86
Resistance 2 (R2) 0.86 0.85 0.86 0.85
Resistance 1 (R1) 0.84 0.84 0.84 0.84 0.85
Pivot Point 0.83 0.83 0.83 0.83 0.83
Support 1 (S1) 0.81 0.82 0.81 0.81 0.79
Support 2 (S2) 0.80 0.81 0.80 0.79
Support 3 (S3) 0.78 0.80 0.78
Support 4 (S4) 0.78